LEADER 01183nam--2200397---450-
001 990001104020203316
005 20030217161844.0
010   $a0-8247-8226-7
035   $a000110402
035   $aUSA01000110402
035   $a(ALEPH)000110402USA01
035   $a000110402
100   $a20021118d1991----km-y0enga50------ba
101 0 $aeng
102   $aUS
105   $ay|||z|||001yy
200 1 $aUlcer Disease$einvestigation and basis for therapy$fEdward A. Swabb, Sandor Szabo
210   $aNew York [etc.]$cM. Dekker$d1991
215   $aXI, 527 p.$d23 cm
225 2 $aClinical pharmacology$v17
410  0$12001$aClinical pharmacology$v17
606 0 $aUlcera peptica
676   $a616.343
700  1$aSWABB,$bEdward A.$0554308
701  1$aSANDOR,$bSzabo$0554309
801  0$aIT$bSalbc$cISBD
912   $a990001104020203316
951   $a616.343 ULC$b3202 FAR$c616$d00099280
959   $aBK
969   $aFAR
979   $aMARIA$b10$c20021118$lUSA01$h1140
979   $aCHIARA$b90$c20030217$lUSA01$h1617
979   $aCHIARA$b90$c20030217$lUSA01$h1618
979   $aPATRY$b90$c20040406$lUSA01$h1716
996   $aUlcer Disease$9977616
997   $aUNISA